跳至主要内容
临床试验/NCT03179735
NCT03179735Unknown4 期

Mouthwashes as Positive Modulators of Periodontal Response During Orthodontic Treatment: a 6-month Randomized Placebo Controlled Clinical Trial

University of Taubate1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2017年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
60
试验地点
1
主要终点
Changes in gingival index

研究概览

简要总结

The number of orthodontic treatment provided to Brazilian population has been increased. Unfortunately, some negative effects such as gum bleeding and bad breath are commonly observed. It partially happens because tooth brushing and flossing become more difficult in the presence of braces. Therefore, there is a need for clinical protocols able to maintain the mouth healthy during orthodontic treatment.

Considering that proper use of mouthwashes by in individuals without braces is accompanied by decrease in plaque and gum inflammation levels, it was hypothesized that, during orthodontic treatment their anti-gingivitis and anti-plaque properties would positively affect oral health. Objectives: The present study will compare the effects of two commercially available mouthwashes with a placebo mouthwash in orthodontic patients wearing fixed appliances.

Whole-mouth clinical examinations will be performed in periodontally healthy patients 15 days before, at the day of bonding and also 3 and 6 months after braces bonding. Hard and soft tissues status, presence of gingivitis and amount of dental plaque will be monitored to determine mouthwashes efficacy. At these same time-points plaque samples will be collected from dental sites and braces surfaces aiming at determining total levels of bacteria and levels of specific bacteria related to gum disease. After a full-mouth ultrasonic debridement to remove dental plaque, stains and tartar, patients will be randomly assigned to an Essential oils, Cetylpyridinium chloride or a placebo mouthwash for 6 months (40 ml/day). Further, samples of orthodontic wires will be analyzed under microscopy to check whether regular use of mouthwashes increases the risk of corrosion or not.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • good general health;
  • class I or class II malocclusions with a nonsurgical orthodontic treatment plan for alignment and leveling including no-extraction, extraction of two upper premolars or extraction of four premolars; no previous orthodontic treatment; overbite and overjet that allowed brackets to be placed on the lower teeth without occlusal interferences;
  • periodontal health (with no clinical signals of inflammation, GI <1 e no clinical attachment loss);
  • at least 26 natural teeth;

排除标准

  • severe skeletal malocclusion in anteroposterior, vertical or transverse dimensions; surgical orthodontic plan;
  • mouth breathing;
  • gingivitis; periodontitis; gingival overgrowth;
  • prosthetic fixed devices, removable partial dentures or overhanging restorations;
  • systemic diseases or conditions that could influence the periodontal status;
  • smokers and former-smokers;
  • pregnancy or breast-feeding;
  • history of sensitivity or suspected allergies following the use of oral hygiene products; any antibiotic prophylaxis;
  • antibiotics and/or anti-inflammatory drug use in the six months prior to the beginning of the study;
  • regular use of chemotherapeutic antiplaque/antigingivitis products;
  • periodontal treatment performed within six months prior to study initiation;
  • unwillingness to return for follow-up.

研究组 & 干预措施

Essential oils mouthwash

Experimental

Essential-oils group will rinse with an alcohol-free mouthwash (twice daily use; 20 ml/30 s) containing a fixed combination of four essential oils (eucalyptol 0.092%, menthol 0.042%, methyl salicylate 0.060%, thymol 0.064%)

干预措施: Essential oils (Drug)

Cetylpyridinium mouthwash

Experimental

Cetylpyridinium chloride group will rinse with an alcohol-free mouthwash (twice daily use; 20 ml/30 s) containing cetylpyridinium chloride 0.7 mg/ml

干预措施: Cetylpyridinium Chloride 0.7 mg/ml (Drug)

Placebos mouthwash

Placebo Comparator

Placebo group will rinse with an alcohol-free placebo solution (twice daily use; 20 ml/30 s)

干预措施: Placebos (Drug)

结局指标

主要结局

Changes in gingival index

时间窗: up to 6 months

Gingival index changes (mean scores) from baseline to 6 months.

次要结局

  • Changes in plaque index(up to 6 months)
  • Changes in subgingival bacterial levels(up to 6 months)
  • Changes in bracket bacterial levels(up to 6 months)
  • Changes in gingival overgrowth measurements(up to 6 months)
  • Corrosion of orthodontic devices(up to 6 months)

研究者

发起方
University of Taubate
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验